Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema

Somya Dulani, Rajesh Dulani, Seema Lele, Sachin Diagavane, Sandeep Anjankar, Netra Jaiswal, Prem S. Subramaniam, Rakesh Juneja

Ophthalmology JNMC DattaMeghe, Institute of Medical Sciences, Wardha, India.

DOI: 10.4236/cm.2012.34027                

Abstract

Subdural hematomas are often life-threatening when acute but chronic subdural hematomas, however, have better prognosis if properly managed. Chronic subdural hematomas are common in the elderly due to shrinkage of brain tissue, but in young patient mostly associated with head injury. It is seen also in young having various coagulopathies associated with blood disorders or drug-induced, but it is very rare. Propylthiouracil (PTU) is an oral medication that is used in treatment of hyperthyroidism approved by FDA in July 1947. This medication may rarely cause very serious blood disorders (such as a low number of red cells, white cells, and platelets), especially during the first few months of treatment. We are reporting a rare case of PTU-induced thrombocytopenia leading to chronic subdural haematoma, which presented with established papilledema and signs of raised ICP in a hyperthyroid female and she responded well to surgical management.

Keywords

Propylthiouracil (PTU); Thrombocytopenia; Papilledema

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	A. Downie, “Tutorial: CT in Head Trauma,” 2007.
[2]	A. Prystupa, E. Kurys-Denis, T. ?opatyński, J. Baraniak and W. Krupski, “Case Report: Chronic Subdural Haematoma in a Patient with Arterial Hypertension and Alzheimer’s Disease,” Journal of Pre-Clinical and Clinical Research, Vol. 3, No. 2, 2009, pp. 127-129.
[3]	L. Bartalena, F. Bogazzi and E. Martino, “Adverse Effects of Thyroid Hormone Preparations and Antithyroid Drugs,” Adverse Effects of Thyroid Hormone Preparations and Antithyr, Vol. 15, No. 1, 1999, pp. 53-63. doi:10.2165/00002018-199615010-00004
[4]	Medicine Net.com, “Newsletter Medicationspropylthiouracil Drug Monograph,” 2012. http://www.medicinenet.com
[5]	eHealth Me, “Real World Drug Outcomes. Could Hyperthyroidism Causes Subdural Haematoma,” 2012. http://www.ehealthme.com
[6]	E. Yaka and R. ?akmur, “Increased Intracranial Pressure Due to Hyperthyroidism,” Cephalalgia, Vol. 30, No. 7, 2010, pp. 878-880.
[7]	U. Herwig and M. Sturzenegger, “Hyperthyroidism Mimicking Increased Intracranial Pressure,” Headache: The Journal of Head and Face Pain, Vol. 39, No. 3, 1999, pp. 228-230.
[8]	E. Coutinho, A. M. Silva, C. Freitas1 and E. Santos, “Graves’ Disease Presenting as Pseudotumorcerebri: A Case Report,” Journal of Medical Case Reports, Vol. 5, 2011, p. 68. doi:10.1186/1752-1947-5-68
[9]	U. Herwig and M. Sturzenegger, “Brief Communication: Thyroid Function in Patients with Chronic Headache,” International Journal of Neuroscience, Vol. 57, No. 3-4, 1991, pp. 263-267.
[10]	J. C. T. Chen and M. L. Levy, “Causes, Epidemiology and Risk Factors of Chronic Subdural Hematoma,” Neurosurgery Clinics of North America, Vol. 11, No. 3, 2000, pp. 399-406.